Levothyroxine
sodium pentahydrate (LSP; C15H10I4NNaO4·5H2O) gradually loses
one molecule of water of crystallization as the water vapor pressure
is decreased from 90% to 15% RH (40 °C), a behavior characteristic
of nonstoichiometric hydrates. LSP loses four molecules of water of
crystallization to form levothyroxine sodium monohydrate (LSM; C15H10I4NNaO4·H2O) under realistic storage conditions (40 °C/0% RH for 3 h).
The crystal structure of LSP was determined following which the specimen
was partially dehydrated in situ to form LSM. The
crystal structure of LSM provided insight into its potential for high
reactivity. Thus, its presence in a drug product is undesirable. In
LSP–oxalic acid mixtures stored in a hermetic container at
40 °C, there was moisture transfer from drug to excipient. Synchrotron
X-ray diffractometry revealed dehydration of LSP resulting in LSM,
while anhydrous oxalic acid transformed to its dihydrate. In formulations
of LSP, chemical degradation of levothyroxine sodium may be preceded
by its partial dehydration.